A bulk ingredient order and a finished supplement project are quoted differently. Choose the supply model before comparing MOQ or pricing.

For ingredient supply: specify species or identity, plant part where applicable, extract ratio or DER, marker, assay method, source, and target quantity.

For finished products: add dosage form, serving size, full active list, destination market, packaging, artwork requirements, and target units.

Important: A 25 kg ingredient MOQ is not equivalent to a 5,000-unit private-label MOQ. If the brief contains both raw-material sourcing and finished-product manufacturing, they should be quoted as separate commercial lines.

Who formulates, how the ingredient is specified, how the batch is tested, and how the finished unit is released sit in one file. Line figures match Manufacturing Capacity. Methods and release records sit with Quality Control. Formula development sits with the R&D Center.

Botanical identity. Species, plant part, and extract ratio — not the common name alone.

Marker assay. Bacosides, rosavins / salidroside, withanolides, crocin / safranal, ginkgo 24/6, theanine, phosphatidylserine — tied to a named method.

Mushroom authentication. Fruiting body vs mycelium, and beta-glucans (or another named marker) on the same COA.

Lipid oxidation. Peroxide, anisidine, and TOTOX where DHA or other oils are on the BOM.

Hygroscopic actives. Water activity, handling, and pack for choline salts such as Alpha-GPC.

Finished-unit assay. Printed milligrams versus the result on the finished capsule, gummy, stick, or softgel — not the incoming drum COA alone. How to read that file: How to Read a COA.

Microbiology and contaminants. Heavy metals, pesticides, residual solvents, and micro, aligned with the destination dietary-supplement file.

This is not an FDA product approval. Brand-owner counsel owns Supplement Facts and claim lists.

Compare Two COAs

1. Brief — product path, format, destination, stimulant on or off, serving size.
2. Sourcing — identity, marker, method, approved supplier, secondary source when the botanical is seasonal.
3. Feasibility — fill window, gummy load, oil phase, bitterness, moisture.
4. Pilot — a production-relevant batch before commercial scale-up.
5. Testing — identity, assay, micro, contaminants, finished-unit assay as scoped.
6. Production — in-process controls on the agreed format.
7. Packaging — bottle, sachet / stick, or blister; climate lane named when choline salts or fish oil are on the BOM.

Certificates, when they apply to the site: cGMP, ISO9001, ISO22000, HACCP, FSSC22000, HALAL, and KOSHER. See Certifications. Certificates are not a substitute for the finished-unit assay.

• 4 GAP-certified cultivation bases for botanicals that need a traceable farm file, not a sourcing slogan.
• 12 production lines across capsules, tablets, powders, gummies, softgels, and scoped liquids.
• Pilot production is validated before commercial scale-up; finished-unit timing depends on formula complexity, packaging, and testing.
• Private-label MOQ typically starts at 5,000 units. High-load choline, mushroom dual-extract panels, and some gummy cooks can raise the first batch.
• Samples for evaluation. Typical first reply within one business day on a complete brief. Project manager assigned. NDA available.

Can you manufacture both bulk cognitive ingredients and finished products?
Yes. A cognitive health ingredients supplier or nootropic ingredient supplier brief is a named isolate or extract, quoted by the kilogram. Finished brain-boost private label units follow a finished-unit MOQ, pack, and artwork file. Do not treat a drum quote as a bottle MOQ.

What information do you need to quote a cognitive supplement?
Product pathway, each printed active with milligrams or marker, assay method where relevant, source when it changes identity (fruiting body vs mycelium, soy vs sunflower PS, algal vs fish DHA), stimulant status, dosage form, serving size, destination, pack, and target quantity. Incomplete briefs are still accepted; locked fields make two quotations comparable.

Can you formulate caffeine-free nootropic products?
Yes. Caffeine-free is a BOM rule: no anhydrous caffeine, no tea-caffeine contribution unless it is declared. Calm-focus briefs typically lock L-theanine milligrams and, when used, an adaptogen identity and marker. If caffeine stays on the label, lock milligrams and anhydrous vs natural before artwork.

Can you standardize botanical extracts to a named marker?
Yes, when the incoming specification names the marker and method — bacosides, rosavins / salidroside, withanolides, crocin / safranal, ginkgo 24/6, beta-glucans. “Extract 10:1” without a marker is a different quote from a standardized extract.

Can you manufacture cognitive gummies with high active loads?
Gummies are quoted after a cook-and-assay feasibility. Load, flavor, pectin vs gelatin, and finished-piece assay are the constraints. High-bacoside Bacopa and hygroscopic 99% Alpha-GPC are usually a poor first gummy brief; capsules or a lower-load formula are the usual start.

Can you supply fruiting-body Lion’s Mane rather than mycelium?
Yes. Fruiting body, mycelium, and dual extract are three identities. Lock plant part, beta-glucans (or another named marker), and extraction method. Erinacines or hericenones print only with a method.

Can you provide COA and finished-product testing?
Yes. Incoming identity and assay, plus finished-unit assay against the printed milligram or marker as scoped, with micro and contaminant panels aligned to the destination file. Third-party testing is available when the brief requires it.

What is the typical MOQ for cognitive supplement private label?
Finished-unit MOQ typically starts at 5,000 units. Format, high-load choline, mushroom dual-extract panels, and some gummy cooks can raise the first batch. Kilogram ingredient supply is quoted separately.

Can you formulate for the US, EU, Mexico or LATAM markets?
Yes. Name the destination on the RFQ. Ingredient class (for example GABA or melatonin), claim language, and pack can change by country. We provide manufacturing feasibility and documentation support. Brand-owner counsel owns finished-label compliance. Southeast Asia and the Middle East follow the same rule: destination first, then formula lock.

Can you develop adaptogen supplements for mental alertness?
Yes. Daytime mental-alertness briefs usually start on Rhodiola with named rosavins and method. Evening or burnout briefs start on ashwagandha with withanolides and method. That is not a caffeine brain-boost SKU unless the BOM adds a locked stimulant line.